• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Ilaris (canakinumab)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2012

Summary View

 

PATIENT INFORMATION

What are the possible side effects of Ilaris?
  • Decrease in white blood cells (neutropenia) which help your body fight infections